CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total	Stockholders’ (Deficit) Equity	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive (Loss)	Treasury stock, at cost	Non-controlling interest
Balance at Dec. 31, 2021	$ 99,442	$ 99,442	$ 11	$ 747,928	$ (648,376)	$ (121)
Balance (in Shares) at Dec. 31, 2021			96,546,611
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of RSUs
Vesting of RSUs (in Shares)			1,185,152
Issuance of RSAs
Issuance of RSAs (in Shares)			270,164
Cancellation of RSAs (in Shares)			(57,282)
Cancellation of RSAs
Exercise of common stock options
Exercise of common stock options (in Shares)			116,692
Exercise of common warrants	56	56		56
Exercise of common warrants (in Shares)			4,308,307
Stock-based compensation expense	25,252	25,252		25,252
Common stock received for tax withholding (in Shares)			(1,177)
Common stock received for tax withholding	(4)	(4)					(4)
Issuance of shares related to acquisition (in Shares)			4,042,837
Issuance of shares related to acquisition	17,736	13,868	$ 1	13,867				3,868
Redemption of non-controlling interests (in Shares)			5,961
Redemption of non-controlling interests	6	27		27				(21)
Net loss	(40,116)	(40,116)			(40,116)
Foreign currency translation adjustment	1,492	1,492				1,492
Balance at Dec. 31, 2022	103,864	100,017	$ 12	787,130	(688,492)	1,371	(4)	3,847
Balance (in Shares) at Dec. 31, 2022			106,417,265
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of RSUs
Vesting of RSUs (in Shares)			2,547,619
Issuance of RSAs
Issuance of RSAs (in Shares)			458,755
Exercise of common stock options	73	73		73
Exercise of common stock options (in Shares)			260,228
Exercise of common warrants	882	882		882
Exercise of common warrants (in Shares)			408,231
Stock-based compensation expense	20,207	20,207		20,207
Issuance of common warrants	22,843	22,843		22,843
Redemption of non-controlling interests (in Shares)			719,693
Redemption of non-controlling interests	660	3,145		3,145				(2,485)
Interest payment through issuance of shares (in Shares)			448,466
Interest payment through issuance of shares	1,888	1,888		1,888
Reclassification of warrant liability to common stock warrants	1,248	1,248		1,248
Shares received from settlement of employee receivables (in Shares)			(128,035)
Shares received from settlement of employee receivables	(661)	(661)					(661)
Net loss	(71,735)	(71,735)			(71,735)
Foreign currency translation adjustment	827	827				827
Balance at Dec. 31, 2023	$ 80,096	$ 78,734	$ 12	$ 837,416	$ (760,227)	$ 2,198	$ (665)	$ 1,362
Balance (in Shares) at Dec. 31, 2023			111,132,222